Attached files

file filename
EX-10.29 - MEMBERSHIP INTEREST PURCHASE AGREEMENT BETWEEN REGISTRANT AND AJE MANAGEMENT, LL - GB SCIENCES INCex_198533.htm
10-K - FORM 10-K - GB SCIENCES INCgblx20200331_10k.htm
EX-10.38 - PROMISSORY NOTE PAYABLE TO JOHN DAVIS DATED NOVEMBER 15, 2019 - GB SCIENCES INCex_198701.htm
EX-10.37 - 8% PROMISSORY NOTE PAYABLE TO AJE MANAGEMENT, LLC DATED DECEMBER 3, 2020 - GB SCIENCES INCex_198693.htm
EX-10.36 - LOAN AGREEMENT BETWEEN REGISTRANT AND AJE MANAGEMENT, LLC DATED DECEMBER 3, 2019 - GB SCIENCES INCex_198694.htm
EX-10.35 - SECOND AMENDED AND RESTATED PROMISSORY NOTE BETWEEN REGISTRANT AND CSW VENTURES, - GB SCIENCES INCex_198687.htm
EX-10.34 - SECOND AMENDMENT TO NOTE DOCUMENTS BETWEEN REGISTRANT AND CSW VENTURES, LP DATED - GB SCIENCES INCex_198685.htm
EX-10.33 - AMENDMENT TO PROMISSORY NOTE BETWEEN REGISTRANT AND CSW VENTURES, LP DATED OCTOB - GB SCIENCES INCex_198656.htm
EX-10.32 - FIRST AMENDED PROMISSORY NOTE BETWEEN REGISTRANT AND CSW VENTURES, LP - GB SCIENCES INCex_198595.htm
EX-10.31 - AMENDMENT TO NOTE DOCUMENTS BETWEEN REGISTRANT AND CSW VENTURES, LP DATED JULY 1 - GB SCIENCES INCex_198593.htm
EX-10.30 - MANAGEMENT SERVICES AGREEMENT BETWEEN REGISTRANT AND AJE MANAGEMENT, LLC DATED D - GB SCIENCES INCex_198548.htm
EX-32.2 - EXHIBIT 32.2 - GB SCIENCES INCex_187212.htm
EX-32.1 - EXHIBIT 32.1 - GB SCIENCES INCex_187211.htm
EX-31.2 - EXHIBIT 31.2 - GB SCIENCES INCex_187210.htm
EX-31.1 - EXHIBIT 31.1 - GB SCIENCES INCex_187209.htm
EX-21.1 - SUBSIDIARIES OF GB SCIENCES, INC. - GB SCIENCES INCex_187208.htm
EX-3.4 - EXHIBIT 3.4 AMENDMENT TO ARTICLES OF INCORPORATION - GB SCIENCES INCex_199385.htm
EX-3.3 - EXHIBIT 3.3 ARTICLES OF INCORPORATION - GB SCIENCES INCex_199384.htm

Common Stock

 

The holders of common stock are entitled to one vote per share on all matters to be voted on by stockholders and are entitled to receive such dividends, if any, as may be declared from time to time by our board of directors from funds legally available therefore, subject to the dividend preferences of the preferred stock, if any. Upon our liquidation or dissolution, the holders of common stock are entitled to share ratably in all assets available for distribution after payment of liabilities and liquidation preferences of the preferred stock, if any. Holders of common stock have no preemptive rights, no cumulative voting rights and no rights to convert their common stock into any other securities. Any action taken by holders of common stock must be taken at an annual or special meeting or by written consent of the holders of over 33% of our capital stock entitled to vote on such action.